155 related articles for article (PubMed ID: 38061722)
1. Cases of Pernio-Like Lesions after mRNA-1273 Vaccination with Clinical and Pathological Features: A Single-Center Experience.
Ryoo YW; Yun JM; Kim HW; Lee HW; Jung HR; Kim SA
Ann Dermatol; 2023 Nov; 35(Suppl 2):S281-S286. PubMed ID: 38061722
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
McMahon DE; Amerson E; Rosenbach M; Lipoff JB; Moustafa D; Tyagi A; Desai SR; French LE; Lim HW; Thiers BH; Hruza GJ; Blumenthal KG; Fox LP; Freeman EE
J Am Acad Dermatol; 2021 Jul; 85(1):46-55. PubMed ID: 33838206
[TBL] [Abstract][Full Text] [Related]
3. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
Petruzzi M; Galleggiante S; Messina S; Della Vella F
BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study.
McMahon DE; Kovarik CL; Damsky W; Rosenbach M; Lipoff JB; Tyagi A; Chamberlin G; Fathy R; Nazarian RM; Desai SR; Lim HW; Thiers BH; Hruza GJ; French LE; Blumenthal K; Fox LP; Freeman EE
J Am Acad Dermatol; 2022 Jan; 86(1):113-121. PubMed ID: 34517079
[TBL] [Abstract][Full Text] [Related]
5. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.
Seirafianpour F; Pourriyahi H; Gholizadeh Mesgarha M; Pour Mohammad A; Shaka Z; Goodarzi A
Dermatol Ther; 2022 Jun; 35(6):e15461. PubMed ID: 35316551
[TBL] [Abstract][Full Text] [Related]
6. Vaccine Toes Are the New COVID Toes.
Hodge B; Daniel CR; Elewski BE
Skin Appendage Disord; 2022 Apr; 37(4):1-4. PubMed ID: 35664444
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review.
Kroumpouzos G; Paroikaki ME; Yumeen S; Bhargava S; Mylonakis E
Microorganisms; 2022 Mar; 10(3):. PubMed ID: 35336199
[TBL] [Abstract][Full Text] [Related]
8. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
9. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
[TBL] [Abstract][Full Text] [Related]
10. Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!
Gronbeck C; Grant-Kels JM
Clin Dermatol; 2021; 39(4):674-687. PubMed ID: 34809772
[TBL] [Abstract][Full Text] [Related]
11. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries.
Freeman EE; McMahon DE; Lipoff JB; Rosenbach M; Kovarik C; Takeshita J; French LE; Thiers BH; Hruza GJ; Fox LP;
J Am Acad Dermatol; 2020 Aug; 83(2):486-492. PubMed ID: 32479979
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study.
Bernardi FF; Mascolo A; Sarno M; Capoluongo N; Trama U; Ruggiero R; Sportiello L; Fusco GM; Bisogno M; Coscioni E; Iervolino A; Di Micco P; Capuano A; Perrella A
Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896978
[TBL] [Abstract][Full Text] [Related]
13. Dermatopathology of COVID-19 infection and vaccination.
Fernández-Figueras MT
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):114-118. PubMed ID: 36197514
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Vaccination in Korea.
Park WB; Hwang YH; Cheong HJ
Infect Chemother; 2023 Mar; 55(1):135-149. PubMed ID: 37021429
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
[TBL] [Abstract][Full Text] [Related]
16. Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin.
Singh R; Freeman EE
Curr Dermatol Rep; 2022; 11(4):289-312. PubMed ID: 36274754
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous adverse reactions following COVID-19 vaccinations: A systematic review and meta-analysis.
Shafie'ei M; Jamali M; Akbari Z; Sarvipour N; Ahmadzade M; Ahramiyanpour N
J Cosmet Dermatol; 2022 Sep; 21(9):3636-3650. PubMed ID: 35861631
[TBL] [Abstract][Full Text] [Related]
18. Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis.
Maranini B; Ciancio G; Cultrera R; Govoni M
Reumatismo; 2021 Nov; 73(3):. PubMed ID: 34814659
[TBL] [Abstract][Full Text] [Related]
19. Vertigo and Dizziness After Coronavirus Disease-2019 Vaccination: A Nationwide Analysis.
Kim SH; Yon DK; Choi YS; Lee J; Park KH; Lee YJ; Park DC; Kim SS; Rim HS; Yeo SG
J Int Adv Otol; 2023 Jun; 19(3):228-233. PubMed ID: 37272641
[TBL] [Abstract][Full Text] [Related]
20. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
Shay DK; Gee J; Su JR; Myers TR; Marquez P; Liu R; Zhang B; Licata C; Clark TA; Shimabukuro TT
MMWR Morb Mortal Wkly Rep; 2021 May; 70(18):680-684. PubMed ID: 33956784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
